IS5694A - Bóluefni - Google Patents
BóluefniInfo
- Publication number
- IS5694A IS5694A IS5694A IS5694A IS5694A IS 5694 A IS5694 A IS 5694A IS 5694 A IS5694 A IS 5694A IS 5694 A IS5694 A IS 5694A IS 5694 A IS5694 A IS 5694A
- Authority
- IS
- Iceland
- Prior art keywords
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809958.3A GB9809958D0 (en) | 1998-05-08 | 1998-05-08 | Vaccine |
| GBGB9811954.8A GB9811954D0 (en) | 1998-05-08 | 1998-06-03 | Vaccine |
| GBGB9812316.9A GB9812316D0 (en) | 1998-06-08 | 1998-06-08 | Cancer vaccines |
| PCT/GB1999/001461 WO1999058145A2 (en) | 1998-05-08 | 1999-05-10 | Immunomodulators for vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5694A true IS5694A (is) | 2000-10-31 |
Family
ID=27269307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5694A IS5694A (is) | 1998-05-08 | 2000-10-31 | Bóluefni |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1075274A2 (ru) |
| JP (1) | JP4666761B2 (ru) |
| KR (1) | KR20070067719A (ru) |
| CN (1) | CN100335130C (ru) |
| AU (1) | AU3939499A (ru) |
| BR (1) | BR9910305A (ru) |
| CA (1) | CA2331832A1 (ru) |
| CZ (1) | CZ302333B6 (ru) |
| EA (1) | EA004794B1 (ru) |
| GB (1) | GB2353472A (ru) |
| HU (1) | HUP0104842A3 (ru) |
| IL (1) | IL139467A (ru) |
| IS (1) | IS5694A (ru) |
| MX (1) | MXPA00010934A (ru) |
| NO (1) | NO20005599L (ru) |
| NZ (1) | NZ507911A (ru) |
| PL (1) | PL344519A1 (ru) |
| WO (1) | WO1999058145A2 (ru) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9513371D0 (en) | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
| GB9326174D0 (en) | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
| US20010036917A1 (en) | 1995-07-05 | 2001-11-01 | Williams Neil Andrew | Therapeutic agents |
| GB9622660D0 (en) | 1996-10-31 | 1997-01-08 | Biocine Spa | Immunogenic detoxified mutant toxin |
| US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
| KR20010043441A (ko) | 1998-05-08 | 2001-05-25 | 더 유니버시티 오브 브리스톨 | 백신용 면역조절제 |
| US7115730B1 (en) | 1999-04-27 | 2006-10-03 | Chiron Srl | Immunogenic detoxified mutant E. coli LT-A-toxin |
| GB0030067D0 (en) * | 2000-12-11 | 2001-01-24 | Univ Bristol | Therapeutic agent |
| GB0115382D0 (en) * | 2001-06-22 | 2001-08-15 | Univ Bristol | Mutant |
| CN111100824B (zh) * | 2020-01-21 | 2021-11-05 | 暨南大学 | 一株芽孢杆菌及其在养殖水体中脱氮除硫的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990006366A1 (en) * | 1988-12-07 | 1990-06-14 | University Of Leicester | Heat-labile toxin b subunit fusion proteins |
| US5241053A (en) * | 1990-09-05 | 1993-08-31 | Takeda Chemical Industries, Ltd. | Fused proteins comprising glycoprotein gD of HSV-1 and LTB |
| GB9513733D0 (en) * | 1995-07-05 | 1995-09-06 | Univ Bristol | Therapeutic agents |
| EP0919243A1 (en) * | 1997-11-25 | 1999-06-02 | Duphar International Research B.V | Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant |
| WO1999036088A1 (en) * | 1998-01-16 | 1999-07-22 | Maxim Pharmaceuticals, Inc. | RECOMBINANT CtB-BASED VACCINES |
-
1999
- 1999-05-10 WO PCT/GB1999/001461 patent/WO1999058145A2/en not_active Application Discontinuation
- 1999-05-10 JP JP2000547996A patent/JP4666761B2/ja not_active Expired - Fee Related
- 1999-05-10 CA CA 2331832 patent/CA2331832A1/en not_active Abandoned
- 1999-05-10 KR KR1020077011045A patent/KR20070067719A/ko not_active Application Discontinuation
- 1999-05-10 NZ NZ507911A patent/NZ507911A/en unknown
- 1999-05-10 HU HU0104842A patent/HUP0104842A3/hu unknown
- 1999-05-10 CN CNB998084034A patent/CN100335130C/zh not_active Expired - Fee Related
- 1999-05-10 GB GB0027072A patent/GB2353472A/en not_active Withdrawn
- 1999-05-10 PL PL34451999A patent/PL344519A1/xx unknown
- 1999-05-10 EA EA200001134A patent/EA004794B1/ru not_active IP Right Cessation
- 1999-05-10 EP EP19990922284 patent/EP1075274A2/en not_active Withdrawn
- 1999-05-10 MX MXPA00010934A patent/MXPA00010934A/es not_active IP Right Cessation
- 1999-05-10 CZ CZ20004147A patent/CZ302333B6/cs not_active IP Right Cessation
- 1999-05-10 AU AU39394/99A patent/AU3939499A/en not_active Abandoned
- 1999-05-10 BR BR9910305A patent/BR9910305A/pt not_active Application Discontinuation
-
2000
- 2000-10-31 IS IS5694A patent/IS5694A/is unknown
- 2000-11-05 IL IL139467A patent/IL139467A/en not_active IP Right Cessation
- 2000-11-06 NO NO20005599A patent/NO20005599L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005599L (no) | 2001-01-08 |
| EA004794B1 (ru) | 2004-08-26 |
| NO20005599D0 (no) | 2000-11-06 |
| BR9910305A (pt) | 2001-01-09 |
| IL139467A0 (en) | 2001-11-25 |
| WO1999058145A3 (en) | 2000-02-03 |
| HUP0104842A2 (hu) | 2002-04-29 |
| CZ302333B6 (cs) | 2011-03-16 |
| WO1999058145A2 (en) | 1999-11-18 |
| IL139467A (en) | 2011-11-30 |
| EA200001134A1 (ru) | 2001-08-27 |
| CN1308546A (zh) | 2001-08-15 |
| KR20070067719A (ko) | 2007-06-28 |
| CN100335130C (zh) | 2007-09-05 |
| MXPA00010934A (es) | 2003-07-14 |
| JP2002514607A (ja) | 2002-05-21 |
| CA2331832A1 (en) | 1999-11-18 |
| HUP0104842A3 (en) | 2002-12-28 |
| GB0027072D0 (en) | 2000-12-20 |
| GB2353472A (en) | 2001-02-28 |
| JP4666761B2 (ja) | 2011-04-06 |
| CZ20004147A3 (en) | 2001-05-16 |
| NZ507911A (en) | 2004-04-30 |
| EP1075274A2 (en) | 2001-02-14 |
| PL344519A1 (en) | 2001-11-05 |
| AU3939499A (en) | 1999-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20006191D0 (no) | Vaksine | |
| NO20003302L (no) | Vaksine | |
| NO20014323L (no) | Vaksine | |
| NO20004758L (no) | Vaksinesammensetning | |
| DE69938817D1 (de) | Erstellungsverfahren | |
| ATE341990T1 (de) | Sigmidoskop | |
| DE59901560D1 (de) | Retrograder tibianagel | |
| DE59902874D1 (de) | Buchsenkontakt | |
| DE59907306D1 (de) | Fadenchangierung | |
| DE60002650D1 (de) | Öladjuvierter Impfstoff | |
| NO20020763L (no) | Vaksine | |
| DE59906931D1 (de) | Exzenterzahnradgetriebe | |
| DE59908968D1 (de) | Benzoylpyridazine | |
| DE59903966D1 (de) | Exzenterzahnradgetriebe | |
| DE59908769D1 (de) | N-arylsulfonyl-aminosäure-omega-amide | |
| DE59903106D1 (de) | Tripode-gleichlaufdrehgelenk | |
| NO20005599L (no) | Vaksine | |
| DE59901046D1 (de) | Methylcyclotetradec-5-en-1-one | |
| DE59908057D1 (de) | Underdruckhandhabungseinrichung | |
| DE59807217D1 (de) | Nadellager | |
| DE19842103B4 (de) | Stanznietzuführung | |
| DE59808995D1 (de) | Endomikroskopsystem | |
| DE59902088D1 (de) | Achrathermer Reimager | |
| DE59900612D1 (de) | Dispersionsazofarbstoffmischungen | |
| DE59903616D1 (de) | Rollenwicklerwalze |